Gabriele Conti is a Bioanalytical Principal Investigator at Celerion, leading GxP bioanalysis for clinical studies and method validations. With over five years of experience in medicinal chemistry and bioanalysis, Gabriele has contributed to various phases of drug discovery and development. Gabriele holds a PhD in Pharmaceutical Sciences, along with an MSc and BSc in Chemistry, and has completed research roles at esteemed institutions including Universiteit Utrecht and Universität Basel. Prior experience includes positions at Teva Pharmaceuticals and Idorsia Pharmaceuticals Ltd, among others.
This person is not in the org chart
This person is not in any teams
This person is not in any offices